Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 1.97B P/E - EPS this Y 67.50% Ern Qtrly Grth -
Income -278.43M Forward P/E -11.45 EPS next Y -34.10% 50D Avg Chg -11.00%
Sales 65.86M PEG 0.60 EPS past 5Y - 200D Avg Chg 4.00%
Dividend N/A Price/Book 2.77 EPS next 5Y -10.76% 52W High Chg -38.00%
Recommedations 2.30 Quick Ratio 2.19 Shares Outstanding 224.31M 52W Low Chg 57.00%
Insider Own 45.27% ROA -24.52% Shares Float 123.54M Beta 2.62
Inst Own 20.14% ROE -54.30% Shares Shorted/Prior 5.51M/5.65M Price 8.82
Gross Margin -131.00% Profit Margin - Avg. Volume 695,441 Target Price 8.00
Oper. Margin -493.58% Earnings Date Nov 12 Volume 129,216 Change -2.97%
About CureVac N.V.

CureVac N.V., a biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA). It is developing prophylactic vaccines, such as mRNA-based vaccine candidates CV2CoV, which is in Phase 1 clinical trial against SARS-CoV-2; CV7202 which is in Phase 1 clinical trial for the treatment of rabies; and CVSQIV to treat multivalent seasonal influenza; Flu SV mRNA fot treating nucleotides, single antigen seasonal influenza. The company develops CV8102, which is in Phase 1 clinical trial for treating melanoma and adenoidcystic carcinoma, as well as squamous cell cancer of skin, head, and neck; and CVGBM for treating cancer. CureVac N.V. was founded in 2000 and is headquartered in Tübingen, Germany.

CureVac N.V. News
11/28/24 Cerus And 2 Other US Penny Stocks To Watch
11/26/24 Loss-Making CureVac N.V. (NASDAQ:CVAC) Set To Breakeven
11/20/24 Is the Options Market Predicting a Spike in CureVac (CVAC) Stock?
11/19/24 Is CureVac N.V. (CVAC) the Best German Stock to Buy Now?
11/15/24 Where are they now? 4 biotechs that soared then crashed during the pandemic
11/13/24 CureVac NV (CVAC) Q3 2024 Earnings Call Highlights: Strong Financial Performance and Strategic ...
11/12/24 CureVac Announces Financial Results for the Third Quarter and First Nine Months of 2024 and Provides Business Update
11/07/24 CureVac to Report Third Quarter and First Nine Months 2024 Financial Results and Business Update on November 12, 2024
11/04/24 CureVac Strengthens Leadership Team with Appointment of Seasoned Industry Executive Axel Sven Malkomes as Chief Financial Officer
11/04/24 CureVac to Present at the 12th International mRNA Health Conference
10/30/24 US Penny Stocks To Watch In October 2024
10/30/24 GSK Cuts Vaccine Sales Outlook Amid U.S. Weakness
10/28/24 CureVac to Present at the Society for Immunotherapy of Cancer (SITC) 39th Annual Meeting
10/08/24 Pfizer, BioNTech win bid to invalidate CureVac's UK COVID vaccine patents
10/01/24 CureVac N.V.'s (NASDAQ:CVAC) top owners are individual investors with 35% stake, while 31% is held by private equity firms
09/13/24 CureVac's CVGBM Cancer Vaccine Induces Promising Immune Responses in Phase 1 Study in Glioblastoma Presented at the ESMO 2024 Congress
09/12/24 GSK's HSV Vaccine Study Fails to Meet Primary Efficacy Goal
09/12/24 CureVac Partner GSK Announces Positive Phase 2 Data from Seasonal Influenza mRNA Vaccine Program
09/09/24 CureVac to Present First CVGBM Glioblastoma Cancer Vaccine Clinical Data at ESMO 2024 Congress
08/21/24 News Flash: 8 Analysts Think CureVac N.V. (NASDAQ:CVAC) Earnings Are Under Threat
CVAC Chatroom

User Image Gisbert2212 Posted - 23 hours ago

$CVAC maybe worth a try 🧐 @FiboSnail what do you think

User Image Luked9999 Posted - 2 days ago

$AEMD next runner can be $NNVC Bird flu play too. $VRAX $CVAC $DYAI

User Image Andrewfritzen01 Posted - 2 days ago

$CVAC wen moon

User Image EVinsanity Posted - 3 days ago

$CVAChttps://x.com/radarhits/status/1869471125073445370?s=46&t=EslJhdoVhKYF1I-mWxHHrw

User Image Underdog2016 Posted - 4 days ago

$BNTX $MRNA $NVAX $CVAC $PFIZER.NSE Should We Unleash GMO Mosquitoes? https://on.soundcloud.com/8WRWvuEGnUqkM8HY7

User Image Article_AI Posted - 6 days ago

$CVAC 2 Small-Cap Stocks Set to Shine in a Bull Market Small-cap stocks often experience outsized gains during bullish markets. Their smaller market capitalizations and growth-oriented profiles make them more sensitive to improving economic conditions, where rising investor confidence drives capital toward higher-risk, higher-reward opportunities. https://www.stck.pro/news/CVAC/96329924/

User Image Underdog2016 Posted - 1 week ago

$MRNA put/call ratio 13,34 at Jan 17.. https://www.reddit.com/r/Shortsqueeze/s/fzNtktgl1U $CVAC $NVAX $BNTX $GSK

User Image PharmaRevolution Posted - 1 week ago

$MRNA $BNTX Moderna strinking inexcusably due to spraying all their Covid revenue in little thought through pipelines. Slowing leaving the field for Biontech to take the dominant place in future mRNA technology. Looking more like $CVAC than Biontech in their trajectory.

User Image ZH1982 Posted - 1 week ago

$CVAC wow, very strong

User Image lasmanoz Posted - 1 week ago

$CVAC whats going on? why is it going up

User Image DocPharm Posted - 1 week ago

$ABUS buying another cold hard block tomorrow with some crypto cash $ROIV $CVAC & $PFE too Roche, I’ve loaded enough

User Image DocPharm Posted - 1 week ago

$CVAC a forgotten name by many, hell, they made most of biotech that way Be just slightly savvier than those around you, big money has the time advantage

User Image ZH1982 Posted - 1 week ago

$CVAC nice day. It might take time but the future is bright 🙂

User Image Chrissytina Posted - 1 week ago

$CVAC $MRNA $NVAX This is a new account that’s posting lies and bullshit!!!Take it all and shove it up your ass…blocked/reported

User Image Underdog2016 Posted - 1 week ago

$MRNA JFK jr. Himself is buying . Uhhh vax me up, baby 🥰💉🚀 $CVAC $NVAX

User Image DocPharm Posted - 1 week ago

$CVAC sitting’ pretty, finally Took a bit - avg a hair under 3

User Image Underdog2016 Posted - 1 week ago

$MRNA Welcome back Cathie Wood. Any other whales are still sleaping?? $CVAC $BNTX $NVAX $GRRR

User Image Underdog2016 Posted - 1 week ago

$MRNA is Disease X a scam? $CVAC

User Image KUMU Posted - 1 week ago

$CVAC took a position on this stock

User Image ZH1982 Posted - 1 week ago

$BBAI $PLTR $CVAC going strong!

User Image Andrewfritzen01 Posted - 2 weeks ago

$CVAC people scared to buy at this price in July but oh how price action is king .

User Image mhaven2020 Posted - 2 weeks ago

$RMSL it looks like 0.0144 is the first major resistance to cross. It would cause a breakout to happen. Support at 0.0070. Also scoping $CVAC for biotechnology, $PSHIF for oil and services, $SIGA in pharma. Going through the FDA calendar soon. All of the mentioned will be covered in upcoming vids. Do you want me to look at something for you? Want a video on your stock? Let me know...

User Image yus37 Posted - 2 weeks ago

$CVAC 👍

User Image Underdog2016 Posted - 2 weeks ago

$GME $CVAC $GRRR 🧬🦍🚀🌒

User Image Underdog2016 Posted - 2 weeks ago

$GRRR apes hit the moon 🦍🚀🌒 i put all my cap for today in the morning (GER) in $CVAC WATCH OUT 🧬💉 another intresting nasdaq stock aim for the moon!

User Image Underdog2016 Posted - 2 weeks ago

@arubaboy add in GER in the morning hole cap for today in $CVAC they break 100ma and now attack 200ma in one day. WATCH OUT 🧬💉 another nasdaq winner until now..

User Image Underdog2016 Posted - 2 weeks ago

$CVAC feels like High Vol from market close yesterday will continue before the weekend.. $PFIZER.NSE $MRNA $GSK $NVAX

User Image Underdog2016 Posted - 2 weeks ago

$CVAC Hits 100ma . 200ma realy closely to cross today before weekend.. $GSK $NVAX $MRNA - since yesterday a passenger from congo with flu symptomes is isolated near cleveland in a hospital ..

User Image Leon_32 Posted - 2 weeks ago

$NVAX $CVAC $MRNA $BNTX $XBI https://www.technologyreview.com/2024/11/29/1107552/risk-of-bird-flu-pandemic-rising/amp/

User Image justiceforb_85 Posted - 2 weeks ago

$CVAC good to see their top listed pipeline is the glioblastoma cancer vaccine. They appear to have strong data and could be first to market for this.

Analyst Ratings
JMP Securities Market Outperform Sep 16, 24
JMP Securities Market Outperform Aug 16, 24
JMP Securities Market Outperform Jul 3, 24
Leerink Partners Market Perform Apr 25, 24
Guggenheim Neutral Apr 5, 24
Guggenheim Buy Apr 26, 21
Credit Suisse Underperform Dec 10, 20
B of A Securities Buy Sep 8, 20
Jefferies Hold Sep 8, 20